Cargando…
The Key Role of NAD(+) in Anti-Tumor Immune Response: An Update
Nicotinamide adenine dinucleotide (NAD(+)) is an important molecule that functions as a co-enzyme in numerous metabolic processes. Generated both through de novo synthesis and via salvage pathways, NAD(+) is the substrate for a variety of NAD(+)-consuming enzymes. Among them is CD38, a cell surface...
Autores principales: | Morandi, Fabio, Horenstein, Alberto Leonardo, Malavasi, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082456/ https://www.ncbi.nlm.nih.gov/pubmed/33936090 http://dx.doi.org/10.3389/fimmu.2021.658263 |
Ejemplares similares
-
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
por: Horenstein, Alberto L., et al.
Publicado: (2019) -
CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018) -
NAD(+)-Metabolizing Ectoenzymes in Remodeling Tumor–Host Interactions: The Human Myeloma Model
por: Horenstein, Alberto L., et al.
Publicado: (2015) -
Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche
por: Chillemi, Antonella, et al.
Publicado: (2017) -
Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells
por: Morandi, Fabio, et al.
Publicado: (2019)